Document:

<PAGE>   1
                                                                    EXHIBIT 10.4

                        EXCLUSIVE MANUFACTURING AGREEMENT

         This EXCLUSIVE MANUFACTURING AGREEMENT is entered into effective as of
this 8th day of May, 2001, by and among INNOVATIVE BOTANICAL SOLUTIONS, INC., a
manufacturer ("IBS"), with its principal offices at 75 East 1700 South, Provo,
Utah, and CETALON CORPORATION, a retailer ("Cetalon"), with its principal
offices at 1801 Avenue of the Stars, Suite 600, Los Angeles, California 90067
(each a "Party," and collectively, the "Parties").

                                    RECITALS

WHEREAS, Cetalon is in the business of retailing herbal and homeopathic
products, vitamin and mineral supplements and personal care products; and

WHEREAS, IBS is in the business of designing, researching, formulating,
developing, manufacturing, packaging, distributing and marketing nutritional
products and has demonstrated its capability to develop formulae and to
manufacture nutritional products derived from such formulae; and

WHEREAS, Cetalon desires to utilize the expertise of IBS to design, research,
formulate, develop, manufacture and package nutritional products for Cetalon to
market and distribute; and

WHEREAS, IBS desires to design, develop, research, formulate, manufacture and
package nutritional products for Cetalon;

NOW, THEREFORE, incorporating the above recitals herein, and in consideration of
the covenants and obligations contained herein and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the
Parties agree as follows:

     1.       DEFINITIONS

         1.1 "CUSTOM PRODUCTS" means the Products set forth on Exhibit D.

         1.2 "FDCA" means the Federal Food, Drug and Cosmetic Act, as amended
from time to time, together with all regulations issued by the Food and Drug
Administration and other governmental agencies pursuant thereto.

         1.3 "FORMULAS" means all technical documentation, memoranda, records,
notes, data, formulas, formulations, processes, specifications, standards and
procedures, designs, techniques, concepts, methods, ingredients, sketches,
drawings, know-how, flow charts, reference materials, bills of materials,
recipes, menus and other work product, works-in-progress (whether or not each
respective element is complete) and materials (in each case whether or not
reduced to tangible form), that have been or are at any time generated or
conceived, whether before, on or after the date of this Agreement, in connection
with the development, manufacture and supply of Products, whether developed by
or on behalf of IBS or Cetalon, and any and all (a) modifications, derivatives,
alterations, improvements, enhancements or successors thereof, whether developed
by or on behalf

                                        1
<PAGE>   2
of IBS or Cetalon, and (b) patents, copyrights, trademarks, service marks, trade
dress, know-how, proprietary or confidential information or other intellectual
or industrial property rights (whether or not reduced to tangible form) included
in, pertaining to or associated with the foregoing.

         1.4 "FTCA" means the Federal Trade Commission Act, as amended from time
to time, together with all regulations issued by the Federal Trade Commission
and other governmental agencies pursuant thereto.

         1.5 "NEW PRODUCTS" means any and all new nutritional products developed
by the Parties hereto pursuant to Section 2 and as set forth on Exhibit A hereof
as amended from time to time by writings signed by both Parties.

         1.6 "PRIVATE LABEL PRODUCT(S)" or "PRODUCT(S)" means all nutritional
foods, nutritional and dietary supplements and related materials or products of
any description, including but not limited to New Products, capsules, tablets,
powders, liquids, bars and other forms and packaged in any and all manners using
the names, styles, patents, trademarks, logos, domain names, copyrights and all
other attributes ("Private Label Mark") now owned or licensed or hereafter
acquired or licensed in any manner by Cetalon or its Affiliates (as defined in
Section 18) for retail distribution.

         1.7 "PRODUCT PRICES" means the prices at which Products shall be sold
by Nature's Sunshine to Cetalon hereunder and which prices, if available, are
listed in Exhibit B hereof as amended from time to time by writings signed by
both Parties.

         1.8 "SPECIFICATIONS" means such specifications and quality control
requirements for the Products and for any ingredients and packaging materials as
determined by the Parties from time to time.

         1.9 "TECHNICAL INFORMATION" means all customer and business information
and all formulae, quality control data, test data and all other scientific and
technical data and information relating to the Products which are now owned or
controlled by the Parties or which may hereafter be developed by any Party in
connection with the Products.

2.       PRODUCT DEVELOPMENT

         2.1 Initial Development and Formulation. IBS will develop New Products
for Cetalon subject to the terms and conditions of this Agreement, and with the
collaboration and assistance of Cetalon. IBS will design, formulate the
Specifications for manufacture, and package the New Products. Cetalon will
collaborate and cooperate with IBS and otherwise assist IBS with designing and
formulating the Specifications for such New Products.

         2.2 Packaging and Labels. Cetalon will develop all packaging and
labeling with respect to the New Products and reserves the right to determine
the requirements of such packaging and labeling, provided that IBS, in its
discretion, shall have the right to reject any packaging and labeling that does
not comply with all applicable laws, rules and regulations, including, without
limitation, FDCA regulations. Cetalon shall collaborate and cooperate with IBS
and otherwise assist IBS in implementing the packaging and labeling
requirements, so determined, of the New Products.

                                       2
<PAGE>   3
         2.3 Design Approval by Cetalon. The initial design, formulation and
packaging of all Products and all material changes thereto, and all similar
matters concerning the Products, their design, research, formulation,
development, manufacture, packaging and labeling will be subject to the approval
of Cetalon, which approval shall not be unreasonably withheld.

3.   PRODUCTION, ROLLING FORECAST, PURCHASE ORDERS, INVENTORY, STORAGE, SHIPPING
     AND REPORTS

         3.1 Purchase Requirements: Cetalon shall purchase Products in
compliance with the minimum purchase requirements and minimum store requirements
outlined in Exhibit C attached hereto. If Cetalon fails at any time to meet
either of such minimum requirements, IBS shall have the right to terminate this
Agreement upon three (3) months written notice to Cetalon.

         3.2 Production. IBS shall manufacture and package Products in
quantities ordered by Cetalon in accordance with the terms and conditions set
forth in this Agreement; provided, however, that IBS shall not be required to
manufacture and package a Product if IBS determines, in its discretion, that (i)
such Product poses a health risk to consumers of such Product, (ii) the raw
materials required for the production of such Product can not be obtained for a
commercially reasonable price, or (iii) the production of such Product infringes
on the intellectual property of a third party. IBS may develop for its own use
in manufacturing the Products such manufacturing specifications and quality
control parameters as it may deem appropriate and will comply with all
Specifications.

         3.3 Rolling Forecast. Within ninety (90) days of the date of this
Agreement, Cetalon shall provide IBS with a twelve (12) month forecast of its
Product needs. Thereafter, on the last day of each month, Cetalon shall provide
IBS with a purchase forecast update covering the following twelve (12) months;
provided that the estimates for the first three months of such updated forecast
shall not change from the estimates provided for those months in the previous
updated forecast (the "Rolling Forecast"). Except as provided in Sections 3.4
and 14.5, such forecasts provided by Cetalon shall be only for production and
planning and capacity planning purposes by IBS and negotiations with materials
vendors, and shall not constitute purchase orders.

         3.4 Purchase Orders. Upon the execution of this Agreement, Cetalon
shall provide IBS with an estimate of initial purchases covering the first three
(3) months of purchases (the "Initial Estimates"), and a purchase order for the
first month's purchases. Thereafter, Cetalon shall submit monthly purchase
orders no later than the fifth day of each month for Products to be delivered
the following month. Unless otherwise consented to by IBS in writing, which
shall not be unreasonably withheld, purchase orders covering the first three (3)
months of purchases may not deviate up or down from the Initial Estimates with
respect to Custom Products by more than twenty percent (20%), and subsequent
purchase orders may not deviate up or down from the Rolling Forecast then in
effect with respect to Custom Products by more than ten percent (10%).

             3.5 Inventory. IBS shall order and maintain an inventory of raw
materials and packaging materials sufficient to meet Cetalon's supply needs as
determined by the purchase orders and annual forecasts needed to maintain a
rolling ninety (90) day supply.

                                       3
<PAGE>   4
             3.6 Storage and Shipment. IBS shall provide suitable storage and
warehousing space for all Products for the time and to the extent required for
IBS to perform its obligations under this Agreement. Products are to be stored
in clean space suitable for storage of dietary supplements and protection of its
contents with respect to integrity and quality, in compliance with good
commercial practice and all applicable laws, rules and regulations, including,
without limitation, FDCA regulations. IBS shall load Products onto such carriers
as may be determined by IBS. All Products are delivered F.O.B. IBS's dock and
all risk of loss of the Products shall remain with IBS until loaded onto such
carriers unless Cetalon and IBS shall otherwise mutually agree. The carrier
selection, shipment and payment procedures and bill of lading requirements shall
be subject to Cetalon's approval which approval shall not be unreasonably
withheld and shall be in accordance with any reasonable instructions issued by
Cetalon. Products are to be shipped via clean trucks and trailers suitable for
transportation of dietary supplements and protection of its contents with
respect to integrity and quality, in compliance with good commercial practice
and all applicable laws, rules and regulations, including, without limitation,
Department of Transportation regulations. IBS is responsible for arranging for
carriers and pursuing claims against carriers for any failure to meet these
requirements.

         3.7 Production and Shipping Reports. IBS shall provide Cetalon with
production reports and shipment of finished goods reports, in such form as
Cetalon reasonably requests. Reports from IBS's facilities shall be sent to
Cetalon by facsimile in the manner set forth in Section 17.1.

         3.8 Inventory Reports. IBS shall provide Cetalon with periodic reports
of IBS's inventories of Cetalon's finished Products and materials. The report
shall be delivered by facsimile in the manner set forth in Section 17.1.

4.       IBS'S EXCLUSIVITY

         4.1 Requirements. Cetalon agrees to order and purchase from IBS all
requirements it or they may have, from time to time, for all Private Label
Products, and to do so in accordance with the provisions of this Agreement.
Cetalon will enter into no other agreement for the purchase or manufacture of
Private Label Products that IBS is capable of and interested in producing during
the term of this Agreement without the prior written consent of IBS.

         4.2 Failed Conditions. In connection with the Products referenced
herein, if following diligent investigation, inquiry and conference with IBS,
Cetalon in good faith does not believe IBS satisfies any one or more of the
material conditions contained herein or any Products are not being manufactured
in material conformance with the Specifications, Cetalon shall give IBS written
notice of such determination. Such notice shall state in detail the condition(s)
IBS does not satisfy, the reasons Cetalon believes IBS does not satisfy the
stated condition(s), and a detailed statement of facts that would have to exist
for IBS to satisfy the failed condition(s). IBS shall have sixty (60) days
following receipt of the written notice referenced in this Section to cure any
inability or failure to satisfy any condition(s) listed in a notice from
Cetalon.

         4.3 Effect of Failed Condition. In the event IBS does not cure its
inability to satisfy the conditions contained in a notice received from Cetalon
pursuant to Section 4.2 within the time

                                       4
<PAGE>   5
periods set forth to the reasonable satisfaction of Cetalon acting in good
faith, then Cetalon may enter into a manufacturing, supply or similar agreement
with a third party for the manufacture or supply of only the Product or Products
that fail to meet such conditions.

         4.4 Product Development and Promotion. Cetalon shall diligently work to
develop the line of Products to be manufactured under this Agreement and shall
cause its employees, agents and other representatives to use their best efforts
to promote the sale of such Products.

5. MEANS OF PRODUCTION. IBS shall furnish and maintain, at its own cost and
expense, all equipment necessary to manufacture and package the Products in
accordance with the Specifications and in compliance with federal, state and
local laws, rules and regulations.

6. COMPENSATION, PAYMENT, MATERIALS AND TITLE

         6.1 Compensation. As full and complete compensation for all services
performed and Products sold hereunder, IBS shall be entitled to receive
compensation on a per Product basis at the price set forth for each Product on
Exhibit B. Not less than thirty (30) days prior to the first shipment of any New
Product or any change in price of a current Product, IBS shall notify Cetalon of
any such price or change. Prices for each Product shall be determined by IBS at
a price equal to the Direct Manufacturing Costs plus a margin of 28%. For
purposes hereof, "Direct Manufacturing Costs" shall mean all costs of producing,
manufacturing, handling and storing the Products, including without limitation
materials, labor, storage, manufacturing overhead, all federal, state and local
taxes that may be imposed on the sale or manufacture of the Products, Custom
Batch Premiums and all other costs of manufacture, but shall not include
administrative overhead, research and development costs, or other items
specifically excluded pursuant to this Agreement. For purposes of the preceding
sentence, "Custom Batch Premium" shall mean a reasonable premium determined in
good faith by IBS charged on a product by product basis for any Products on
which the actual monthly purchase falls below the standard minimum batch size of
1,000 bottles or other sales unit, as such batch size may be reasonably revised
from time to time in accordance with IBS's standard operating practices.

         6.2 Costs. IBS agrees to use its best efforts to contain costs by
obtaining competitive prices on raw and packaging materials and by operating
efficiently. Cetalon shall be entitled to audit, at reasonable times and places
and at its own cost, any underlying documents relating to ingredients, packaging
materials and other costs used by IBS to determine the price for Products.

         6.3 Invoices. Invoices for Products shall be sent to Cetalon at the
time of shipment. Payment terms shall be 1/10 net 75. A late charge of 1.5%
shall be paid by Cetalon for every 30-day period, or part thereof, any invoice
remains unpaid after seventy-five (75) days. If any amounts remain unpaid for
more than seventy-five (75) days after receipt by Celaton of invoice, in
addition to all other rights and remedies available at law or equity, IBS shall
have the right to terminate this Agreement.

         6.4 Inspection. Cetalon and its agents shall have access to IBS's
production plants once each calendar quarter for the purpose of performing
reasonable production, inventory and cost audits

                                       5
<PAGE>   6
pertaining to this Agreement. IBS shall be notified in advance of the names of
all visiting personnel or agents and their intended dates of arrival. As part of
such audit, Cetalon shall also be entitled to audit any underlying documents
relied on by IBS to support any cost determination hereunder.

         6.5 Title. Title and risk of loss to all Products shall be and shall
remain in IBS until placed into the possession of the designated carrier, at
which time title and risk of loss shall transfer to Cetalon, unless Cetalon and
IBS otherwise mutually agree.

7.       QUALITY CONTROL, TESTING

         7.1 Specifications. IBS shall manufacture the Products in accordance
with all applicable laws, rules and regulations, and any manufacturing
Specifications developed by IBS from time to time. Cetalon reserves the right,
on a reasonable basis, to alter, add to or delete such Specifications.

         7.2 Raw Materials. IBS shall store all raw materials, packaging
materials and finished Products in a clean, dry area, free from insects and
rodents, in a manner to prevent entry of foreign materials. Storage and handling
shall be strictly in accordance with the provisions of all applicable laws, the
Specifications and any reasonable written instructions issued by Cetalon and
approved by IBS.

         7.3 Quality of Materials. IBS shall have each shipment of raw materials
and packaging materials, analyzed for such matters as it may reasonably elect
before any said materials can be used in making and packaging the Product. Such
analysis will be in the nature of quality control and may be conducted in-house
by IBS. At Cetalon's request and expense, IBS will initiate outside, third party
laboratory tests at laboratories selected and approved by Cetalon; provided,
however, that if the raw materials or packaging material fail to meet the
Specifications, IBS shall pay the reasonable expense of such outside tests. Any
additional costs directly incurred by IBS as a result of such outside tests,
shall be included as Direct Manufacturing Costs pursuant to Section 6.1.

         7.4 Production Quality. IBS shall perform all in-process and finished
Product checks necessary to assure Product quality. These tests are to be
undertaken as a routine part of the manufacturing process, the cost of which
will be included in the actual costs of production and shall be charged to
Cetalon as a part thereof. All test results shall be documented and summarized
by IBS.

         7.5 Product Release. A Product shall not be released for shipment
unless it complies with the Specifications and all applicable laws, rules and
regulations. IBS shall place any noncomplying Products on hold, and such
noncomplying Products may be released only with the prior approval of both
Parties.

         7.6 Rejected Product; Yield Losses. All rejected Products will be
disposed of in a manner consistent with the law and as approved by all Parties.
Approval thereof shall be provided within five (5) business days of request
therefor, and shall not be unreasonably withheld. The costs of noncomplying and
rejected Products, together with any yield losses incurred in production (net of
any recoveries by IBS) shall be included as part of Direct Manufacturing Costs
pursuant to Section 6.1, except to the extent that such costs exceed reasonable
and customary noncompliance and rejection costs for Products of a similar
nature.

                                       6
<PAGE>   7
         7.7 Codes. Production codes for Products will be maintained in
accordance with IBS's existing policies as of the date hereof, or reasonable and
adequate replacement policies as may be adopted from time to time. IBS shall
maintain such records as required by applicable law on raw and packaging
materials usage, finished Product production by code date and shipping of
Products, so that Products can be traced in case of a recall. Unless necessary
to prevent serious injury or death or as required by law, IBS cannot initiate a
recall or withdrawal of the Products ordered by or shipped to Cetalon without
the consent of Cetalon. If a recall or withdrawal must be initiated before
consent of Cetalon can be obtained, in order to prevent serious injury or death
or as required by law, notice to Cetalon must be provided as soon as is
reasonably feasible.

         7.8 FDCA Standards. IBS's premises shall be kept and maintained in
conformity with, and all Products shall be manufactured consistent with, all
applicable FDCA requirements.

8.       INSPECTION OF MANUFACTURER, REGULATORY ACTION

         8.1 Inspection. IBS's plant shall meet all requirements established by
state, local or federal regulations. Cetalon and its agents shall have access to
IBS's plant at all reasonable times while Products are in process for the
purpose of conducting such inspections and performing quality control audits,
and shall have access to the results of any test performed by IBS or at IBS's
direction related to the Products.

         8.2 Regulatory Action. If the Food and Drug Administration or any other
federal, state or local government agency makes an inquiry regarding the
Products directly or indirectly, or gives notice of or makes an inspection at
any Party's premises, seizes any Product or requests a recall, directs any Party
to take or cease taking any action, the other Party shall be notified
immediately but in no event later than the next business day. Duplicates of any
samples of Product taken by such agency shall be sent to the other Party
promptly. In the event of any action described in this Section, the Parties
shall cooperate in determining the response, if any, to be made to such action
and each Party agrees to cooperate with, assist and allow IBS to be the primary
spokesperson in responding to any communication or inquiry, and/or attempting to
resolve any such action, and to refrain from any activity with respect to such
action which is not previously approved by IBS, unless otherwise required by
law.

9. SAMPLES. IBS shall collect and keep retention samples in accordance with its
general practices for similar products. Sample costs shall be included in Direct
Manufacturing Costs as provided in Section 6.1.

10. WARRANTY, PRODUCT INSPECTION, CUSTOMER RETURNS

         10.1 Warranty. IBS does hereby warrant and guarantee to Cetalon that at
the time of delivery the Products shall (i) comply with all applicable federal,
state and local laws and regulations, including, without limitation, the FDCA
and the FTCA, (ii) not be adulterated or misbranded within the meaning of the
FDCA, (iii) not be an article which, under the provisions of Section 404 and 505
of the FDCA, may not be introduced into interstate commerce, (iv) not be in
violation of the provisions of the Food Additives Amendment of 1958, and (v) be
in full compliance

                                       7
<PAGE>   8
with California's Safe Drinking Water and Toxic Enforcement Act of 1986, as
amended from time to time, and all regulations promulgated thereunder, and are
products which do not require any form of warning under such act.

         10.2 Inspection. Cetalon shall inspect all of the Products shipped
promptly upon receipt thereof, and in no event later than ninety (90) days after
receipt thereof. IBS warrants that the Products (i) will, when delivered to the
designated carrier, conform to the description on the face of the purchase order
relating to such Products; and (ii) will be free of defects in materials and
workmanship. IBS shall, at Cetalon's option, replace (F.O.B. Cetalon's point of
destination) or issue a credit or refund to Cetalon for any nonconforming
Products; provided, however, that such Products are in fact nonconforming and
Cetalon furnishes to IBS written notice, in reasonable detail, of the
nonconformity of the Products within ninety (90) days after the receipt thereof
by Cetalon, provides IBS with a reasonable opportunity to inspect such goods and
offers to return such goods to IBS at IBS's cost.

         10.3 Limitation. The warranty set forth in subsection 10.1 hereof shall
not extend to provide a warranty claim to Cetalon in connection with any
liability for which Cetalon has an obligation to indemnify IBS pursuant to
section 12.2 hereof, and shall not extend to Cetalon's customers or their
customers, if any. IBS shall indemnify, defend and hold Cetalon and its
employees, agents, representatives, directors, officers and shareholders
harmless for, from and against all liabilities, suits, actions, proceedings,
claims, demands, losses, damages, fees, taxes, costs, penalties and expenses
including, but not limited to, reasonable attorneys' and accountants' fees
caused by, arising out of or otherwise related to any defective Products or
product liability claims with respect to any Products that are not covered by
Cetalon's insurance against product liability. In furtherance of this subsection
(b), IBS agrees to name Cetalon as an additional insured on IBS's current
insurance policy and maintain product liability coverage in the amount of Ten
Million Dollars ($10,000,000), with an additional Five Million Dollars
($5,000,000) in excess product liability coverage, for the entire term of this
Agreement; provided, however that the excess product liability coverage shall
not be required to cover, and Cetalon shall not be entitled to any excess
coverage on, any product that contains Ephedra.

         10.4 Standards. In connection with orders of Products hereunder, IBS
will formulate, manufacture and package the Products for Cetalon of the same
quality and with the same care as it uses for its own products. IBS will not
change the packaging or shipping of Products hereunder without Cetalon's prior
consent except for minimum deviations that do not affect the quality of the
Products, or for changes made to comply with changes in law or with a government
order or request.

         10.5 Customer Returns. Notwithstanding anything to the contrary
contained herein, and without limiting the provisions of subsection 10.3 hereof,
if a customer of Cetalon has purchased a Product from Cetalon and is
dissatisfied with such Product, IBS shall, at IBS's option, replace (F.O.B.
Cetalon's point of destination) or issue a credit to Cetalon equal to the price
Cetalon paid to IBS for such Product; provided, however, that (i) the customer
returns the unused portion of the product to Cetalon, (ii) the customer fills
out a satisfaction survey setting forth the customer's name, address, telephone
number, the date of such return, and the reason for the customer's
dissatisfaction, and (iii) Cetalon, at Cetalon's expense, returns such unused
portion and satisfaction survey to IBS

                                       8
<PAGE>   9
with the request for replacement, credit or refund on such Product within thirty
days of receiving the return. Notwithstanding the foregoing, in no event shall
the aggregate amount of replacements, credits and refunds in a given month under
this subsection 10.5 exceed one percent (1%) of Cetalon's purchase orders for
such month.

         10.6 NO ADDITIONAL WARRANTIES. THE WARRANTIES TO REPLACE, OR ISSUE A
CREDIT FOR, DEFECTIVE PRODUCTS AS SET FORTH HEREIN, AND ANY ADDITIONAL WARRANTY
EXPRESSLY STATED TO BE A WARRANTY AND SET FORTH IN WRITING AS PART OF THESE
TERMS HEREIN ARE IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING
BUT NOT LIMITED TO ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A
PARTICULAR PURPOSE.

         10.7 CONSEQUENTIAL DAMAGES. Unless hereafter specifically agreed to
between the Parties, IBS shall not have any liability for consequential damages
or loss of profit or revenue; or loss of use of the Products; provided, however,
that as between IBS and Cetalon, this provisions shall not be construed to alter
IBS's potential product liability for use of the Products.

         10.8 Labor Laws. IBS warrants and represents that IBS will comply with
all applicable labor and employment laws, including, without limitation, all
laws and regulations under the federal Occupational Safety and Health Act
(OSHA), as amended.

11.      PROPRIETARY INFORMATION

         11.1 Proprietary Information. All Technical Information, as defined
herein, or other proprietary information that is owned, licensed or controlled
by a Party at the outset of this Agreement or that is outside the scope of this
Agreement shall be the separate and exclusive property of such Party. All
Technical Information or other proprietary information developed or acquired by
either Party in the performance of this Agreement, shall be the property of IBS,
and Cetalon hereby assigns to IBS any claim to or interest or intellectual
property in such Technical Information or other proprietary information;
provided that Cetalon shall have a worldwide, perpetual, non-transferable right
to use such Technical Information or other proprietary information developed or
acquired by either Party in the performance of this Agreement.

         11.2 Proprietary Assets. During the course of its performance of this
Agreement, IBS may, employing artwork, mechanical and packaging cylinders
furnished by Cetalon, and in compliance with all applicable laws, cause to be
printed on the packaging materials and shipping containers of the Products those
trademarks and/or trade names that Cetalon may designate in writing from time to
time. IBS will not use in any way, and will not remove, alter or change in any
way, any trademark, trade name, logo or other commercial symbol of Cetalon,
without the prior permission of Cetalon.

         11.3 Limited Use. Nothing set forth in this Agreement shall be
construed to grant to a Party any right to or interest in any trademark, trade
name, copyright, patent, trade secret, formula or know-how owned or asserted to
be owned by the other Party or any of its affiliates other than as specifically
set forth herein.

                                       9
<PAGE>   10
12.      INDEMNIFICATION

         12.1.1 Indemnification by IBS. Subject to Sections 10.6 and 12.1.2
herein, IBS shall indemnify and save Cetalon harmless from and against any and
all loss, liability, damages, claims for damages, suits, recoveries, judgments
or executions, including costs, expenses and reasonable attorneys' fees, that
may be claimed, asserted or recovered against Cetalon by any person, firm or
corporation whatsoever or whomsoever, on account of any actual or alleged injury
to person or property or death occurring to any person whatsoever arising out of
any obligation of IBS under this Agreement, out of possession, use of or
consumption by, any person of the Products supplied by IBS to Cetalon under this
Agreement, or out of any actual or alleged injury to person or property or death
occurring to any of IBS's employees, agents or any individual on IBS's premises;
provided Cetalon promptly notifies IBS in writing of the institution of such
action or suit and permits IBS to control its defense and settlement. IBS shall
pay all costs and expenses of any such action or suit, including compensation
and expenses of experts and counsel of its choice and selection, and IBS shall
also pay and save Cetalon free and harmless from any damages or other sum
awarded or assessed in any such action or suit. Cetalon may be represented by
counsel of its own selection at Cetalon's expense, and agrees to cooperate fully
in the defense of any such action or suit and to furnish all the evidence in its
control.

          12.1.2 Indemnification by Cetalon. Cetalon shall indemnify and save
IBS harmless from and against any and all loss, liability, damages, claims for
damages, suits, recoveries, judgments or executions, including costs, expenses
and reasonable attorneys' fees, that may be claimed asserted or recovered
against IBS by any person, firm or corporation whatsoever or whomsoever, on
account of any actual or alleged injury to person or property or death occurring
to any person whatsoever arising out of (i) any obligation of Cetalon under this
Agreement, (ii) labeling or packaging of the Products under this Agreement,
(iii) any sales, statements or other actions or inactions by employees or agents
of Cetalon inconsistent with the labeling or packaging on Products, or (iv) any
actual or alleged injury to person or property or death occurring to any of
Cetalon's employees, agents or any individual on Cetalon's premises; provided
IBS promptly notifies Cetalon in writing of the institution of such action or
suit and permits Cetalon to control its defense and settlement. Cetalon shall
pay all costs and expenses of any such action or suit, including compensation
and expenses of experts and counsel of its choice and selection, and Cetalon
shall also pay and save IBS free and harmless from any damages or other sum
awarded or assessed in any such action or suit. IBS may be represented by
counsel of its own selection at IBS's expense, and agrees to cooperate fully in
the defense of any such action or suit and to furnish all the evidence in its
control.

         12.1.3 Intellectual Property Indemnification. In the event of any claim
that any Product (excluding Content) supplied by IBS to Cetalon infringes any
United States patent, copyright or trade secret of a third party not affiliated
with Cetalon, IBS shall indemnify Cetalon against such claim and infringement,
provided that: (i) Cetalon promptly gives notice to IBS of the claim against
Cetalon alleging such infringement, (ii) Cetalon allows IBS to control the
defense and settlement of such claim, (iii) Cetalon fully cooperates with IBS in
connection with the defense and settlement of such claim, and (iv) if requested
by IBS, Cetalon ceases all use, sale and distribution of the infringing Product
and/or returns all infringing Product on hand to IBS for a refund.
Indemnification of Cetalon against such infringement means: (a) to pay any
monetary judgment awarded to the third party based

                                       10
<PAGE>   11
on the claim of such infringement or to pay any settlement amount to the third
party to settle the claim of such infringement, and (b) to defend Cetalon
against such claim. IBS has no other obligation or liability in the event of
infringement and is not responsible for loss of profits or other losses of or
damages to Cetalon. IBS has no other obligation of indemnification or to defend
or hold harmless relating to infringement of patents, copyrights, trade secrets
or other intellectual property. IBS shall not be liable for any costs or
expenses incurred without its prior written authorization. IBS shall have no
obligation of indemnification or any liability if the infringement is based on
or caused by: (a) any altered, changed or modified form of the Product not made
by IBS, or (b) the Product in combination with Cetalon products or anything not
provided by IBS, or (c) any misuse of the Product or any use of the Product
outside of its intended use, or (d) the laws of any country other than the
United States of America or its states. THIS SECTION STATES NEWSUB'S ENTIRE
LIABILITY AND OBLIGATION TO CETALON WITH RESPECT TO INFRINGEMENT OF PATENTS,
COPYRIGHTS, TRADE SECRETS OR ANY OTHER FORM OF INTELLECTUAL PROPERTY.

         In the event of any claim that any Content supplied, requested or
required by Cetalon infringes or causes infringement of any patent, copyright,
trade secret, trademark or other intellectual property of a third party not
affiliated with IBS, Cetalon shall indemnify IBS against such claim and
infringement, provided that: (i) IBS promptly gives notice to Cetalon of the
claim against IBS alleging such infringement, (ii) IBS allows Cetalon to control
the defense and settlement of such claim, (iii) IBS fully cooperates with
Cetalon in connection with the defense and settlement of such claim, and (iv) if
requested by Cetalon, IBS ceases to include or use Content on, in or with
Products and Product packaging and/or returns all infringing Content on hand to
Cetalon. Indemnification of IBS against such infringement means: (a) to pay any
monetary judgment awarded to the third party based on the claim of such
infringement or to pay any settlement amount to the third party to settle the
claim of such infringement, and (b) to defend IBS against such claim. Cetalon
has no other obligation or liability in the event of infringement and is not
responsible for loss of profits or other losses of or damages to IBS. Cetalon
has no other obligation of indemnification or to defend or hold harmless
relating to infringement of patents, copyrights, trade secrets or other
intellectual property. Cetalon shall not be liable for any costs or expenses
incurred without its prior written authorization. Cetalon shall have no
obligation of indemnification or any liability if the infringement is based on
or caused by: (a) any altered, changed or modified form of the Content made by
IBS, or (b) the Content in combination with anything not provided, requested or
required by Cetalon. THIS SECTION STATES CETALON'S ENTIRE LIABILITY AND
OBLIGATION TO NEWSUB WITH RESPECT TO INFRINGEMENT OF PATENTS, COPYRIGHTS, TRADE
SECRETS OR ANY OTHER FORM OF INTELLECTUAL PROPERTY.

         "Content" shall mean any trade marks, names, trade dress, labeling,
packaging, packaging and labeling specifications and/or other packaging and
labeling content provided, required or requested by Cetalon for a Product.

         12.2 Insurance. IBS shall carry with companies reasonably satisfactory
to Cetalon: (i) Workers' Compensation and Employees' Liability Insurance; (ii)
Standard Form Fire and Extended Coverage Insurance for the full replacement
value of any of the Products or any premiums or packaging materials; and (iii)
Public Liability Insurance including Contractual Liability

                                       11
<PAGE>   12
and Products Liability Coverage (with Broad Form Vendor's Endorsement naming
Cetalon and its authorized distributors and customers as insured) with a
combined single limit of not less than Ten Million Dollars ($10,000,000), with
an additional Five Million Dollars ($5,000,000) in excess product liability
coverage for the entire term of this Agreement; provided, however that the
excess product liability coverage shall not be required to cover any product
that contains Ephedra. IBS shall submit policies and/or certificates of
insurance evidencing the above coverage (which shall include an agreement by the
insurer not to cancel or materially alter its coverage except upon thirty (30)
days prior written notice to Cetalon) to Cetalon upon Cetalon's written request
therefore. Products Liability Insurance shall continue in effect for Cetalon's
benefit for a period of one (1) year from the date of the last delivery of
Products to Cetalon. In case of IBS's failure to carry said policies and/or
furnish certificates of insurance or upon cancellation of any required
insurance, Cetalon may, at its option, immediately terminate this Agreement
unless (in the case of cancellation) IBS has obtained substitute insurance
coverage before such insurance becomes canceled and provides Cetalon with
satisfactory evidence thereof.

13. RELATIONSHIP OF THE PARTIES. IBS shall be deemed an independent contractor
with respect to the terms and provisions of this Agreement and it shall not in
any respect act as an agent, employee, partner or joint venturer of Cetalon. All
persons employed in connection with the manufacture and/or supply of the
Products shall be employees or agents of IBS and under no circumstances shall
IBS or any of its employees or agents be deemed to be employees or agents of
Cetalon.

                                       12
<PAGE>   13
14.      TERM OF AGREEMENT.

         14.1 Term. This Agreement shall remain in effect for a period of five
(5) years unless earlier terminated in accordance with this Section. The term
shall be automatically extended for an additional period of five (5) years upon
expiration of the initial term, unless IBS, at its option and in its sole
discretion, elects not to extend by notifying Cetalon in writing, delivered in
accordance with Section 17.1, at least ninety (90) days prior to the expiration
of the initial term.

                  14.2.1 Cetalon Termination. Subject to Sections 3.1 and 4.2
herein, Cetalon may terminate this Agreement prior to the end of its term after
notice to IBS only if IBS materially fails to comply with any covenant in this
Agreement and such failure continues for more than sixty (60) days after written
notice thereof from Cetalon.

                  14.2.2 IBS Termination. Subject to Sections 3.1and 6.3 herein,
IBS may terminate this Agreement prior to the end of its term after notice to
Cetalon only if Cetalon materially fails to comply with any covenant in this
Agreement and such failure continues for more than sixty (60) days after written
notice thereof from IBS.

         14.3 Termination on Specific Events. Either Party may terminate this
Agreement immediately only if:

                  14.3.1 The other Party suspends or discontinues its business
operations, makes any assignment for the benefit of its creditors, commences
voluntary proceedings for liquidation in bankruptcy, admits in writing its
inability to pay its debts generally as they become due or consents to the
appointment of a receiver, trustee or liquidator of the other Party or of all or
any material part of its property, or if there is an execution of a material
portion of its assets.

                  14.3.2 The other Party shall commence any case, proceeding or
other action under any existing or future law of any jurisdiction, domestic or
foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors
seeking to have an order for relief entered with respect to it, or seeking to
adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement,
adjustment, winding-up, liquidation, dissolution, composition or other relief
with respect to it or its debts.

                  14.3.3 (A) There shall be commenced against the other Party
any case, proceeding or other action of a nature referred to in section 14.4.2
above which results in the entry of an order for relief or any such adjudication
or appointment or remains undismissed, undischarged, unstayed or unbonded for
period of ninety (90) days; or (B) there shall be commenced against the other
Party any case, proceeding or other action seeking issuance of a warrant of
attachment, execution, distraint or similar process against all or any
substantial part of its assets, which results in the entry of an order for any
such relief which shall not have been vacated, discharged or stayed or bonded
pending appeal within ninety (90) days from the entry thereof; or (C) the other
Party shall take any action in furtherance of, or indicating its consent to,
approval of or acquiescence in, any of the acts set forth in clause (A) or (B)
above.

                                       13
<PAGE>   14
         14.5 Duties on Termination. Upon termination of this Agreement, copies
of all records related to Cetalon shall be kept by IBS for a minimum of three
(3) years following production. In addition, IBS shall complete all work in
process in a timely fashion and deliver the same to Cetalon as provided herein
against payment as provided herein. To the extent that after such work in
progress has been completed, IBS has inventory of raw materials and packaging
materials on hand that were purchased in good faith reliance upon the rolling
forecasts, then Cetalon shall be liable for, and required to purchase such
inventory from IBS at a price (F.O.B. storage location) equal to actual cost
plus a reasonable charge for carrying, handling and storing such inventory,
within sixty days (60) days from the date that IBS furnishes to Cetalon a
written reconciliation showing the amount of such inventory. Nothwithstanding
Cetalon's obligation to purchase any such inventory from IBS, IBS shall use
commercially reasonable efforts to try to use such inventory for other customers
or sell it to third parties. The Parties shall cooperate to prepare such final
reconciliations of Products and inventory and any other amounts to be provided
as between them in connection with such termination.

15.      CONFIDENTIALITY.

         15.1 Duty to Protect Confidential Information. Any confidential
information disclosed or conveyed by either Party to the other in connection
with its business by written communication and marked as confidential, or by
oral communication and confirmed in writing to be confidential within thirty
(30) working days of oral disclosure, shall be treated by the receiving Party as
confidential proprietary information. The information disclosed shall be held in
trust by the receiving Party for the benefit of the disclosing Party. The
receiving Party shall treat such information as confidential proprietary and/or
trade secret information, and shall take such steps to assure its continued
confidentiality in like manner as it would use to protect its own trade secrets
or confidential information and will not, except as required by law, disclose
any such confidential information received from the other Party to any third
party unless such disclosure is approved in writing by the disclosing Party.

         15.2 Means of Protecting Confidential Information. IBS and Cetalon
agree to take reasonable steps to ensure the proprietary and confidential nature
of the other's confidential information and of the Plants, Products,
Specifications and Technical Information in which confidential information is
embodied or included and to protect the same form loss or theft and agree to
clearly mark such confidential information and properly indicate its proprietary
nature.

         15.3 Terms of Agreement. The Parties agree that the terms contained in
this Agreement are proprietary and confidential, as is the existence of this
Agreement. Each Party agrees to maintain the existence of this Agreement and the
terms and information contained herein strictly confidential and will not
disclose any such information to any person who is not a Party hereto without
the prior written consent of the other Party, which consent shall not be
unreasonably withheld; provided, however, that no consent shall be required to
disclose such information (i) as may be required or appropriate in response to
any summons, subpoena, or discovery order or to comply with any applicable law,
order, regulation (including SEC and FDCA regulations), or (ii) as the Parties
deem appropriate on a confidential basis in order to obtain financing, form
strategic alliances, negotiate acquisitions, or conduct operations in the
ordinary course of business.

                                       14
<PAGE>   15
         15.4 Formulas, Plant, Products, Specifications and Technical
Information. The Parties agree that the formulas, plant, Products,
Specifications and Technical Information defined pursuant to Section 1 as they
relate to New Products are proprietary and confidential to IBS and are furnished
to Cetalon only for the purposes of (i) cooperating in designing, researching,
formulating, developing, manufacturing and packaging the Products, and (ii)
distributing and selling Products in conformance with this Agreement, including
the worldwide, perpetual right of use granted in Section 11.1. Any other use of
the information by Cetalon is understood and agreed by the Parties to constitute
a material breach of this Agreement that cannot be cured.

         15.5 Audits. The Parties agree the information arising, created,
compiled or developed in connection with inspections and audits permitted
pursuant to Sections 6.2, 6.4, 7.3 and 8.1 are proprietary and confidential, and
the information revealed therein is furnished only for the purpose of confirming
compliance with the terms of this Agreement. Any other use of the information
revealed by such inspections or audits is understood and agreed by the Parties
to constitute a material breach of this Agreement that cannot be cured.

         15.6 Extended Term of Confidentiality. It is recognized by all Parties
that due to their respective positions of confidence giving rise to access to
confidential, proprietary information during the term of this Agreement, that
the provisions of this Section 15 apply during the term of this Agreement and
for a period of five (5) years thereafter.

         15.7 Provisions Divisible. It is agreed by the Parties that the
foregoing covenants are appropriate and reasonable in light of the nature and
extent of the business conducted by the Parties and their respective
relationships. It is further agreed that the covenants set forth herein are
divisible in the event they are held to be invalid, unreasonable, arbitrary or
against public policy. Further, it is agreed by the Parties that if any court of
competent jurisdiction makes such a determination, the court may determine what
time period and geographical area are reasonably necessary to protect the
Parties' legitimate business interests and which are enforceable.

         15.8 Irreparable Injury. Each Party acknowledges that damages at law
will be an insufficient remedy for violation of the terms of this Article and
that the other Party would suffer irreparable injury as a result of such
violation. Accordingly, it is agreed the Parties may obtain injunctive relief to
enforce the provisions of this Article of this Agreement, which injunctive
relief shall be in addition to any other rights or remedies available to it or
them.

16.      APPLICABLE LAW.

         16.1 Law. This Agreement shall be construed in accordance with the laws
of the State of Utah, without regard to its rules on conflicts of law.

         16.2 Venue. Subject to the obligation to arbitrate disputes set forth
herein any action or proceeding seeking to enforce any provision of, or based on
any right arising out of, this Agreement may be brought against any of the
Parties only in the courts of the State of Utah, or, if it has or can acquire
jurisdiction, in the appropriate United States District Court for District of
Utah, and each of the Parties consents to such venue and to the jurisdiction of
such courts (and of the appropriate

                                       15
<PAGE>   16
appellate courts) in any such action or proceeding and waives any objection to
venue laid therein. Process in any action or proceeding referred to in the
preceding sentence may be served on any Party anywhere in the world.

         16.3. Arbitration. Any dispute, controversy or claim arising from, out
of or in connection with, or relating to, this Agreement or any breach or
alleged breach of this Agreement, except allegations of violations of Federal or
State securities laws, will upon the request of any Party involved be submitted
to Judicial Arbitration and Mediation Services, Inc. or any private arbitration
service utilizing former judges as mediators and approved by the Parties. The
dispute once submitted shall be settled by arbitration in Salt Lake City, Utah
(or at any other place or under any other form of arbitration mutually
acceptable to Parties involved). The arbitrator shall follow and apply the
federal rules of evidence and applicable local federal rules governing discovery
in the conduct of the arbitration. Any award rendered shall be final, binding
and conclusive upon the Parties and shall be non-appealable, and a judgment
thereon may be entered in the highest State or Federal court of the forum,
having jurisdiction. The expenses of the arbitration shall be borne equally by
the Parties to the arbitration, provided that each Party shall pay for and bear
the cost of its own experts, evidence and attorneys' fees, except that in the
discretion of the arbitrator, any award may include the costs, fees and expenses
of a Party's attorneys.

         16.4. Attorneys Fees. If any arbitration or legal proceeding is brought
for the enforcement of this Agreement, or because of an alleged breach, default
or misrepresentation in connection with any provision of this Agreement or other
dispute concerning this Agreement, the successful or prevailing Party shall be
entitled to recover reasonable attorneys fees incurred in connection with such
arbitration or legal proceeding. The term "Prevailing Party" shall mean the
Party which is entitled to recover its costs in the proceeding under applicable
law, or the Party designated as such by the court or the arbitrator.

17.      NOTICE; DESIGNATION.

         17.1 Notices. Unless otherwise indicated herein, all notices, requests,
demands or other communication sought by the respective Parties hereto shall be
deemed to have been given or made when deposited in the mails, registered or
certified mail, return receipt requested, postage prepaid, or by means of
overnight delivery service when delivered to such service addressed to the
respective Party at the following address:

If to IBS:

                  IBS of IBS Products, Inc.
                  75 East 1700 South
                  P.O. Box 19005
                  Provo, Utah  84605-9005
                  Attention: Dan Howells
                  Telephone: 801-342-4555
                  Facsimile: 801-342-4300

With a copy to:

                                       16
<PAGE>   17
                  Brent Christensen, Esq.
                  Parsons, Behle & Latimer, P.C.
                  201 South Main Street, Suite 1800
                  Salt Lake City, Utah 84145-0898

If to Cetalon:

                  Cetalon Corporation
                  1801 Avenue of the Stars, Suite 600
                  Los Angeles, California 90067
                  Attention: Harvey Goldstein, CEO
                  Telephone: 310-284-5970
                  Facsimile: 310-277-3069

   With a copy to:

                  Dianne Prupas
                  The Watley Group, LLC
                  1801 Avenue of the Stars, Suite 600
                  Los Angeles, California 90067
                  Fax: 604-433-7436

         17.2 Designated Contact. If a specific contact person is designated in
a provision, notice concerning the subject matter of such provision shall be
directed to such person. The address or the name of any Party or contact person
may be changed by sending notice in the manner set forth above.

18. SUCCESSORS, ASSIGNMENT. This Agreement shall inure to the benefit of and be
binding upon the successors and permitted assigns of the Parties. The Parties
may assign their rights and obligations under this Agreement to their
Affiliates; provided, however, that no such assignment shall serve to release
such assigning Party from its obligations under this Agreement. Any such
assignment will not release or discharge them from any liability or obligation
hereunder. The rights and obligations of the Parties may only be assigned to
other than Affiliate after first obtaining the other Party's written consent,
which consent may not be unreasonably withheld. As used herein, Affiliate shall
refer to any person or entity that is under direct or indirect control of, or
under common control with, the applicable Party.

19.      MODIFICATION, SEVERABILITY.

         19.1 Modification. Neither this Agreement nor any part hereof may be
changed, altered or amended orally. Any modification must be by written
instrument signed by the Party against whom enforcement of the change,
alteration or amendment is sought.

         19.2 Severability. If any provision of the Agreement is held
ineffective for any reason, the other provisions shall remain effective. Each
provision of this Agreement shall be considered

                                       17
<PAGE>   18
severable, and if for any reason any provision which is not essential to effect
the basic purposes of this Agreement is determined to be invalid and contrary to
any existing or future law, then such invalidity shall not impair the operation
of or affect those provisions of this Agreement that are valid.

20. FURTHER ASSURANCES. The Parties agree (a) to furnish upon request to each
other such further information, (b) to execute and deliver to each other such
other documents, and (c) to do such other acts and things, all as the other
Party may reasonably request for the purpose of carrying out the intent of this
Agreement and the documents referred to in this Agreement.

21. WAIVER. The rights and remedies of the Parties to this Agreement are
cumulative and not alternative. Neither the failure nor any delay by any Party
in exercising any right, power or privilege under this Agreement or the
documents referred to in this Agreement will operate as a waiver of such right,
power or privilege, and no single or partial exercise of any such right, power
or privilege will preclude any other or further exercise of such right, power or
privilege or the exercise of any other right, power or privilege. To the maximum
extent permitted by applicable law, (a) no claim or right arising out of this
Agreement or the documents referred to in this Agreement can be discharged by
one Party, in whole or in part, by a waiver or renunciation of the claim or
right unless in writing signed by the other Party; (b) no waiver that may be
given by a Party will be applicable except in the specific instance for which it
is given; and (c) no notice to or demand on one Party will be deemed to be a
waiver of any obligation of such Party or of the right of the Party giving such
notice or demand to take further action without notice or demand as provided in
this Agreement or the documents referred to in this Agreement.

22. ENTIRE AGREEMENT. This Agreement supersedes all prior agreements between the
Parties with respect to its subject matter, and constitutes a complete and
exclusive statement of the terms of the agreement between the Parties with
respect to its subject matter.

23. SECTION HEADINGS, CONSTRUCTION. The headings of Sections in this Agreement
are provided for convenience only and will not affect its construction or
interpretation. All references to "section" or "Sections" refer to the
corresponding Section or Sections of this Agreement. All words used in this
Agreement will be construed to be of such gender or number as the circumstances
require. Unless otherwise expressly provided, the word "including" does not
limit the preceding words or terms.

24. TIME OF ESSENCE. With regard to all dates and time periods set forth or
referred to in this Agreement, time is of the essence.

25. SAVING CLAUSE. If and to the extent any provision of this Agreement is, or
is found by an arbitrator or court of competent jurisdiction to be, prohibited
under, contrary to or ineffective under any existing or future law, this
Agreement shall be considered amended to the smallest degree necessary to make
this Agreement conform to such law and effective thereunder.

26. COUNTERPARTS. This Agreement may be executed in one or more counterparts,
each of which will be deemed to be an original copy of this Agreement and all of
which, when taken together, will be deemed to constitute one and the same
agreement.

                                       18
<PAGE>   19
27. CONFLICTS. Each Party represents and warrants to the other that neither the
execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereunder will violate or constitute a default under
any agreement or instrument previously entered into by any Party or by which any
Party is bound.

28. FORCE MAJEURE. No Party shall be liable to any other Party for its failure
to timely perform any obligations under this agreement when such failure is
substantially the result of fire, flood, epidemic, earthquake, explosion,
accident or similar act of nature or public enemy, labor dispute or strike, riot
or civil disturbance, war (whether declared or undeclared) or armed conflict,
failure of common carrier, any municipal ordinance, any state or federal law,
governmental order or regulation, or order of any court of competent
jurisdiction, or any other similar event or occurrence not within the control of
the Party claiming force majeure.

         IN WITNESS WHEREOF, the parties hereto have duly executed this
Manufacturing Agreement as of the day and year first above written.

INNOVATIVE BOTANICAL SOLUTIONS, INC.         CETALON CORPORATION

By:      __________________________          By:      __________________________
Name:    __________________________          Name:    __________________________
Title:   __________________________          Title:   __________________________

                                       19
<PAGE>   20
                                    EXHIBIT A

                                  NEW PRODUCTS

                [AS MAY BE AMENDED OR UPDATED FROM TIME TO TIME]

IBS shall undertake research and development, as reasonably requested by
Cetalon, for two new product lines of up to 70 SKUs each, (which costs shall be
borne by IBS) or such greater amount of SKU's on terms as the Parties mutually
agree.

                                       20
<PAGE>   21
                                    EXHIBIT B

                               PRODUCTS AND PRICES

                [AS MAY BE AMENDED OR UPDATED FROM TIME TO TIME]

                                       21
<PAGE>   22
                                    EXHIBIT C

                              MINIMUM REQUIREMENTS

PURCHASE GOALS:

In each of the first 5 years following the Closing, Cetalon shall meet the
following minimum annual Purchase Requirements and minimum annual store opening
requirements:

<TABLE>
<CAPTION>
YEAR                                  PURCHASE REQUIREMENT                      STORE OPENINGS
----------------------------------------------------------------------------------------------
<S>                                 <C>                                         <C>
6 Month Requirement                 50 Products in standard                     no minimums
                                    production quantities

1st Anniversary Requirement         $  1,500,000                                50 Stores

2nd Anniversary Requirement         $10,000,000                                 150 Stores

3rd Anniversary Requirement         $30,000,000                                 300 Stores

4th Anniversary Requirement         $50,000,000                                 500 Stores

5th Anniversary Requirement         $75,000,000                                 800 Stores
</TABLE>

                                       22
<PAGE>   23
                                    EXHIBIT D

                                 CUSTOM PRODUCTS

                                       23<PAGE>   1
                                                                    EXHIBIT 10.5

THIS OPTION AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, OR AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER
SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.

           No. O -__                                             OPTION TO
ISSUED:  May 8, 2001                                       PURCHASE COMMON STOCK
Void After: November 4, 2001

                               CETALON CORPORATION

  This Option is issued to Innovative Botanical Solutions, Inc., a Utah
corporation, or its registered assigns ("Holder") by Cetalon Corporation, a
Nevada corporation (the "Company"), on May 8, 2001 (the "Option Issue Date").
This Option is issued in connection with the strategic relationship established
between Holder and the Company through the execution of a certain Exclusive
Manufacturing Agreement by and between Holder and the Company dated as of an
even date herewith (the "Manufacturing Agreement").

  1. PURCHASE OF SHARES. Subject to the terms and conditions hereinafter set
forth, the Holder is entitled, upon surrender of this Option at the principal
office of the Company (or at such other place as the Company shall notify the
holder hereof in writing), to purchase from the Company 458,997 fully-paid,
nonassable shares of Common Stock. The shares of Common Stock issuable pursuant
to this Section 1 (the "Shares") shall also be subject to adjustment pursuant to
Section 8 hereof.

  2. EXERCISE PRICE. The exercise price for the Shares shall be $3.268 per
share, payable in cash or immediately available funds; provided, however, that
up to $1,000,000 of the purchase price shall be payable in the form of a credit
granted to the Company to be used towards the purchase of Products (as that term
is defined in the Manufacturing Agreement) from Holder. Such price shall be
subject to adjustment pursuant to Section 8 hereof (such price, as adjusted from
time to time, is herein referred to as the "Exercise Price").

  3. EXERCISE PERIOD. This Option shall become exercisable, in whole or in part,
commencing upon the Option Issue Date. This Option shall expire with respect to
229,498 shares of Common Stock at 5:00 p.m. on the date that is 90 days after
the Option Issue Date, and it shall expire with respect to the remaining Shares
at 5:00 p.m. on November 4, 2001 after the Option Issue Date; provided, however,
that in the event of (a) the closing of the Company's sale or transfer of all or
substantially all of its assets, or (c) the closing of the acquisition of the
Company by another entity by means of merger, consolidation or other transaction
or series of related transactions, resulting in the exchange of the outstanding
shares of the Company's capital stock such that the stockholders of the Company
prior to such transaction own, directly or indirectly, less than 50% of the
voting power of the surviving entity, this Option shall, on the date of such
event, no longer be exercisable and become null and void. In the event of a
proposed
<PAGE>   2
transaction of the kind described above, the Company shall notify the holder of
the Option at least fifteen (15) days prior to the consummation of such event or
transaction.

  4. METHOD OF EXERCISE. While this Option remains outstanding and exercisable
in accordance with Section 3 above, the Holder may exercise, in whole or in
part, the purchase rights evidenced hereby. Such exercise shall be effected by:

         (a) the surrender of the Option, together with a duly executed copy of
the form of Notice of Election attached hereto, to the Secretary of the Company
at its principal offices; and

         (b) the payment to the Company of an amount equal to the aggregate
Exercise Price for the number of Shares being purchased, which may include a
writing that grants Holder credit to be used towards the purchase of Products
pursuant to Section 2 herein.

  5. CERTIFICATES FOR SHARES. Upon the exercise of the purchase rights evidenced
by this Option, one or more certificates for the number of Shares so purchased
shall be issued as soon as practicable thereafter (with appropriate restrictive
legends, if applicable), and in any event within thirty (30) days of the
delivery of the subscription notice.

  6. ISSUANCE OF SHARES. The Company covenants that the Shares, when issued
pursuant to the exercise of this Option, will be duly and validly issued, fully
paid and nonassessable and free from all taxes, liens, and charges with respect
to the issuance thereof.

  7. RESTRICTIONS ON TRANSFER. The Shares shall be subject to a transfer
restriction (the "Transfer Restriction"). Except as provided in this Section 7,
Holder shall not transfer, assign, encumber or otherwise dispose of any of the
Shares, except that Holder may transfer the Shares to an individual or entity
controlling, controlled by or under the common control with Holder. The Transfer
Restriction shall lapse on the fifth anniversary of the date of this Agreement;
provided, however, that if the Company fails to meet a Minimum Requirement set
forth on Exhibit C to the Manufacturing Agreement, the Transfer Restriction
shall immediately lapse on the date such Minimum Requirement is not met.

  8. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES. The number of and kind
of securities purchasable upon exercise of this Option and the Exercise Price
shall be subject to adjustment from time to time as follows:

         (a) SUBDIVISIONS, COMBINATIONS AND OTHER ISSUANCES. If the Company
shall at any time prior to the expiration of this Option subdivide its Common
Stock, by split-up or otherwise, or combine its Common Stock, or issue
additional shares of its Common Stock or Common Stock as a dividend with respect
to any shares of its Common Stock, the number of Shares issuable on the exercise
of this Option shall forthwith be proportionately increased in the case of a
subdivision or stock dividend, or proportionately decreased in the case of a
combination. Appropriate adjustments shall also be made to the purchase price
payable per share, but the aggregate purchase price payable for the total number
of Shares purchasable under this Option (as adjusted) shall remain the same. Any
adjustment under this Section 8(a) shall become effective at the close of
business on the date the subdivision or combination becomes effective, or as of
the record date of such dividend, or in the event that no record date is fixed,
upon the making of such dividend.

         (b) RECLASSIFICATION, REORGANIZATION AND CONSOLIDATION. In case of any
reclassification, capital reorganization, or change in the Common Stock of the
Company (other than as a result of a subdivision, combination, or stock dividend
provided for in Section 8(a) above), then, as a condition of such
reclassification, reorganization, or change, lawful provision shall be made, and
duly executed documents evidencing the same from the Company or its successor
shall be delivered to the Holder, so that the Holder shall have the right at any
time prior to the expiration of this Option to purchase, at a total
<PAGE>   3
price equal to that payable upon the exercise of this Option, the kind and
amount of shares of stock and other securities and property receivable in
connection with such reclassification, reorganization, or change by a holder of
the same number of shares of Common Stock as were purchasable by the Holder
immediately prior to such reclassification, reorganization, or change. In any
such case appropriate provisions shall be made with respect to the rights and
interest of the Holder so that the provisions hereof shall thereafter be
applicable with respect to any shares of stock or other securities and property
deliverable upon exercise hereof, and appropriate adjustments shall be made to
the purchase price per share payable hereunder, provided the aggregate purchase
price shall remain the same.

         (c) NOTICE OF ADJUSTMENT. When any adjustment is required to be made in
the number or kind of shares purchasable upon exercise of the Option, or in the
Option Price, the Company shall promptly notify the holder of such event and of
the number of shares of Common Stock or other securities or property thereafter
purchasable upon exercise of this Option.

   9. ISSUANCE OF ADDITIONAL STOCK, OPTIONS OR WARRANTS. Notwithstanding
anything to the contrary contained in this Option, the Company agrees that if it
issues, during the next 6 months after the Option Issue Date, any additional
capital stock or warrants or options to purchase any additional capital stock of
the Company (excluding common stock underlying any outstanding debentures,
options, warrants, convertible securities or the like), and if the purchase
price per share of the capital stock or the strike or exercise price for the
warrants or options is less than the Exercise Price (the "Lesser Price"), then
the Company shall forthwith either (i) with respect to Shares already purchased
under this Option, either (a) issue additional shares of common stock to the
Holder to increase the number of shares Holder receives under this Option to the
amount Holder would have received if the Exercise Price had been equal to the
Lesser Price, or (b) refund the difference in cash to the Holder; or (ii) with
respect to Shares still purchasable under this Option, reduce the Exercise Price
to equal the Lesser Price. The foregoing sentence shall not apply to any offer
to sell the Company's Common Stock that has been registered under the Securities
Act.

  10. NO FRACTIONAL SHARES OR SCRIP. No fractional shares or scrip representing
fractional shares shall be issued upon the exercise of this Option, but in lieu
of such fractional shares the Company shall make a cash payment therefor on the
basis of the Exercise Price then in effect.

  11. NO STOCKHOLDER RIGHTS. Prior to exercise of this Option, the Holder shall
not be entitled to any rights of a stockholder with respect to the Shares,
including (without limitation) the right to vote such Shares, receive dividends
or other distributions thereon, exercise preemptive rights or be notified of
stockholder meetings, and such holder shall not be entitled to any notice or
other communication concerning the business or affairs of the Company. However,
nothing in this Section 10 shall limit the right of the Holder to be provided
the Notices required under this Option or the Purchase Agreement.

  12. TRANSFERS OF OPTION. Subject to compliance with applicable federal and
state securities laws, this Option and all rights hereunder shall not be
transferable in whole or in part by the Holder to any person or entity without
the written consent of the Company, except that this Option may be transferred
to an individual or an entity controlling, controlled by or under common control
with the Holder. Permitted transfers shall be recorded on the books of the
Company upon the surrender of this Option, properly endorsed, to the Company at
its principal offices, and the payment to the Company of all transfer taxes and
other governmental charges imposed on such transfer. In the event of a partial
transfer, the Company shall issue to the holders one or more appropriate new
Options.

  13. SUCCESSORS AND ASSIGNS. The terms and provisions of this Option and the
Purchase Agreement shall inure to the benefit of, and be binding upon, the
Company and the Holders hereof and their respective permitted successors and
assigns.
<PAGE>   4
  14. AMENDMENTS AND WAIVERS. Any term of this Option may be amended and the
observance of any term of this Option may be waived (either generally or in a
particular instance and either retroactively or prospectively), with the written
consent of the Company and the Holder.

  15. INVESTMENT INTENT. By accepting this Option, the Holder represents that it
is acquiring this Option for investment and not with a view to, or for sale in
connection with, any distribution thereof.

  16. NOTICES. All notices required under this Option and shall be deemed to
have been given or made for all purposes (i) upon personal delivery, (ii) upon
confirmation receipt that the communication was successfully sent to the
applicable number if sent by facsimile; (iii) one day after being sent, when
sent by professional overnight courier service, or (iv) five days after posting
when sent by registered or certified mail. Notices to the Company shall be sent
to the principal office of the Company (or at such other place as the Company
shall notify the Holder hereof in writing). Notices to the Holder shall be sent
to the address of the Holder on the books of the Company (or at such other place
as the Holder shall notify the Company hereof in writing).

  17. ATTORNEYS' FEES. If any action of law or equity is necessary to enforce or
interpret the terms of this Option, the prevailing party shall be entitled to
its reasonable attorneys' fees, costs and disbursements in addition to any other
relief to which it may be entitled.

  18. CAPTIONS. The section and subsection headings of this Option are inserted
for convenience only and shall not constitute a part of this Option in
construing or interpreting any provision hereof.

  19. GOVERNING LAW. This Option shall be governed by the laws of the State of
Nevada as applied to agreements among residents made and to be performed
entirely within the State of Nevada.

  IN WITNESS WHEREOF, caused this Option to be executed by an officer thereunto
duly authorized.

                                             ________________________________
                                             By: ____________________________
                                             Name and Title
<PAGE>   5
NOTICE OF EXERCISE

To: [CORPORATION NAME]

  The undersigned hereby elects to [check applicable subsection]:

              ____     (a)  Purchase _______________ shares of Series ___
                            Common Stock of ____________, pursuant to the terms
                            of the attached Option and payment of the Exercise
                            Price per share required under such Option
                            accompanies this notice;

AND/OR

              ____     (b)  Exercise the attached Option for ____________ of
                            the shares purchasable under the Option for
                            $________ in credit to be applied towards the
                            purchase of Products pursuant to Section 2 of such
                            Option.

  The undersigned hereby represents and Options that the undersigned is
acquiring such shares for its own account for investment purposes only, and not
for resale or with a view to distribution of such shares or any part thereof.

                                                  OPTIONHOLDER:

                                                  ______________________________
                                                  By: __________________________
                                                        [NAME]

                                       Address:   ______________________________
                                                  ______________________________

 Date: ____________________________________

 Name in which shares should be registered:
 __________________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}]]